Elevance Health Inc (ELV · NYSE)

ELV · MARKET VIEW

Market view · as of Jul 20, 2026

Revenue (TTM)
$201.11B
+1.4% YoY
Gross margin
26.0%
EPS (latest q)
$7.45
vs $6.18 est · beat
52-wk position
66.0%
-12.6% vs 52w high · -4.6% 1mo

Price (last ~year)

Elevance Health shares have declined 10.4% over the past five days, contrasting with a streak of four consecutive earnings beats that included a $7.45 EPS reported for the second quarter of 2026. While the company faces operational headwinds in its Medicaid division, recent filings indicate insider stock purchases by CEO Gail Boudreaux and Director Ramiro Peru. The health benefits company currently holds a $80.92 billion market capitalization with a P/E ratio of 16.5.

Valuation

Market cap
$80.92B
P/E
16.5
PEG
1.321
P/B
1.803
P/S
0.402
Beta
0.683
Analyst target
$449.1

Quality & returns

Gross margin
26.0%
Operating margin
4.6%
Profit margin
2.5%
ROE
11.1%
ROA
3.8%

Price movement

Last
$373.11
1-month
-4.6%
3-month
+14.2%
RSI (14)
42
vs SMA200
+7.6%
52-wk position
66.0% -12.6% vs high

Quarterly trajectory

Revenue by quarter (oldest → newest)

QuarterRevenueOp incomeNet incomeEBITDA
2026-06-30$50.47B$2.06B$1.46B$2.10B
2026-03-31$50.18B$2.66B$1.76B$2.77B
2025-12-31$49.75B$581.0M$547.0M$987.0M
2025-09-30$50.71B$1.76B$1.19B$2.14B

Recent news

Sources this view read

  • fundamentals Company overview & valuation (Alpha Vantage OVERVIEW)
  • filing Quarterly financial statements (Alpha Vantage INCOME/BALANCE/CASH)
  • earnings Reported earnings history (Alpha Vantage EARNINGS)
  • prices Adjusted daily prices (Alpha Vantage TIME_SERIES_DAILY_ADJUSTED)

Other snapshots